Picture Swiss Biotech Association LSUS Swiss Biotech Days 2025 Basel 650x100px

Organisation › Details

3-Dimensional Pharmaceuticals Inc. (3DP)

https://www.3dp.com

	Start	1993-01-01 established
	Group	Johnson & Johnson (JnJ) (Group)
	Industry	pharmaceutical

	Region	Yardley, PA
	Country	United States (USA)
	Street	1020 Three Lower Makefiled Corporate Center, Stony Hill Rd., St. 300
	City	19067 Yardley, PA
		Address record changed: 2020-12-02

Basic data	Employees	n. a.


		Record changed: 2023-07-10

Picture EBD Group BIO-Europe Spring 2025 Milan to 14 Mar 650x200px

More documents for Johnson & Johnson (JnJ) (Group)

[1] Johnson & Johnson Inc.. (1/13/25). "Press Release: Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.". New Brunswick, NJ & Bedminster, NJ....
[2] Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva....
[3] Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA....
[4] Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H...
[5] Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva....
[6] Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil"....
[7] Recursion Pharmaceuticals, Inc.. (4/16/24). "Press Release: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer". Salt Lake City, UT....
[8] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....
[9] Johnson & Johnson. (1/8/24). "Press Release: Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer". New Brunswick, NJ....
[10] LegoChem Biosciences, Inc.. (12/26/23). "Press Release: LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC". Daejeon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]